These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2986643)

  • 1. Involvement of leukocyte peroxidases in the metabolism of tenoxicam.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M
    Biochem Pharmacol; 1985 Apr; 34(8):1337-8. PubMed ID: 2986643
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidation of tenoxicam by leukocyte peroxidases and H2O2 produces novel products.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M; Joly R; Heintz R
    Drug Metab Dispos; 1989; 17(4):463-8. PubMed ID: 2571490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of tenoxicam in rats.
    Ichihara S; Tsuyuki Y; Tomisawa H; Fukazawa H; Nakayama N; Tateishi M; Joly R
    Xenobiotica; 1984 Sep; 14(9):727-39. PubMed ID: 6516446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography.
    Dixon JS; Lowe JR; Galloway DB
    J Chromatogr; 1984 Oct; 310(2):455-9. PubMed ID: 6511864
    [No Abstract]   [Full Text] [Related]  

  • 5. Liquid chromatographic assay of isoxicam in human plasma and urine.
    Bury RW
    J Chromatogr; 1985 Jan; 337(1):156-9. PubMed ID: 3980647
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tenoxicam, a new anti-inflammatory drug, on in vitro neutrophil activation.
    Laghi Pasini F; Capecchi PL; Ceccatelli L; Orrico A; Pasqui AL; Di Perri T
    Boll Chim Farm; 1985 Nov; 124(11):477-82. PubMed ID: 3833264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum concentrations of piroxicam in relation to clinical effectiveness in patients with chronic polyarthritis].
    Siegmeth W
    Wien Med Wochenschr; 1980; 130 Spec No():31-6. PubMed ID: 7456464
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
    Ji HY; Lee HW; Kim YH; Jeong DW; Lee HS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):214-9. PubMed ID: 16169293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of isoxicam and digoxin].
    Zöller B; Engel HJ; Faust-Tinnefeldt G; Gilfrich HJ; Zimmer M
    Z Rheumatol; 1984; 43(4):182-4. PubMed ID: 6495892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piroxicam poisoning.
    Lo GC; Chan JY
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):798. PubMed ID: 6412832
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid chromatographic determination of piroxicam in serum.
    Fraser AD; Woodbury JF
    Ther Drug Monit; 1983 Jun; 5(2):239-42. PubMed ID: 6879650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic determination of peroxidase activity of human leukocytes].
    Morwinski I; Böhme HJ
    Z Med Lab Diagn; 1982; 23(6):356-60. PubMed ID: 6303008
    [No Abstract]   [Full Text] [Related]  

  • 14. The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels.
    Milne GM; Twomey TM
    Agents Actions; 1980 Apr; 10(1 Pt 2):31-7. PubMed ID: 7386306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biliary excretion of tenoxicam in cholecystectomized patients].
    Tamimura H; Mukaihara S; Mine Y; Yotsumoto F; Setoyama M; Suzuki T; Kuruma I
    Nihon Geka Hokan; 1984 Nov; 53(6):779-85. PubMed ID: 6534309
    [No Abstract]   [Full Text] [Related]  

  • 16. [Onset of effect of isoxicam and piroxicam. A double-blind parallel study].
    Bara S; Wagenhäuser FJ
    Fortschr Med; 1985 Jan; 103(4):73-6. PubMed ID: 3972324
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of effect of tenoxicam on glibornuride kinetics and response.
    Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U
    Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of tenoxicam for the treatment of rheumatoid arthritis].
    Torisu T; Nobenaga T; Kwasaki Y
    Ryumachi; 1984 Aug; 24(4):295-308. PubMed ID: 6393367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method].
    Dallegri F; Patrone F; Parodi M; Mela GS; Traverso G
    Boll Soc Ital Biol Sper; 1977 Feb; 53(4):282-4. PubMed ID: 199214
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and biotransformation of methane sulphonanilides with anti-inflammatory activity in the rat and monkey--comparison with piroxicam.
    Krause W; Kühne G; Schillinger E
    Xenobiotica; 1983 May; 13(5):265-72. PubMed ID: 6636822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.